LONDON, May 28, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the market introduction and first commercial procedure of its Tula ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results